Previously, we have reported the results of extensive screening of seven different chemotherapeutics in the presence or absence of four different ICIs in two cell lines, HCC-44 (high expression levels of PD-L1) and A549 (low expression levels of PD-L1) [8]. This evidence concerns the gene CD274 and hepatocellular carcinoma.